Back to TCRX
CITADEL ADVISORS LLC TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
7
Latest value
$16K
Q3 2026
Peak value
$963K
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $233K |
| Q1 2026 | $88K |
| Q2 2026 | $26K |
| Q2 2026 | $963K |
| Q2 2026 | $26K |
| Q2 2026 | $963K |
| Q3 2026 | $16K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $16K | 51.8K | — | — |
| Q2 2026 | $963K | 982.8K | — | — |
| Q2 2026 | $26K | 26.4K | — | — |
| Q2 2026 | $963K | 982.8K | — | — |
| Q2 2026 | $26K | 26.4K | — | — |
| Q1 2026 | $88K | 87.3K | — | — |
| Q1 2026 | $233K | 231.2K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M